ASCRS 2023: Cenegermin 0.002%: Effective for corneal nerve regeneration in neurotrophic keratitis

Article

In a presentation at the American Society for Cataract and Refractive Surgery annual meeting in San Diego, Ana Balbuena-Pareja, MSc, explained how cenegermin-bkbj ophthalmic solution 0.002% (Oxervate, Dompé) had a positive effect on corneal nerve regeneration and sensation in patients with neurotrophic keratitis.

Image Credit: © WavebreakmediaMicro - stock.adobe.come

The authors concluded that the patients with neurotrophic keratitis who were treated for at least 4 weeks with cenegermin 0.002% had an overall increase in the total, main, and branch nerve densities. These results also demonstrated a significant increase in corneal sensation after cenegermin treatment. (Adobe Stock/WavebreakmediaMicro)

Ana Balbuena-Pareja, MSc, and colleagues from Tufts Medical Center, Boston, reported that cenegermin-bkbj ophthalmic solution 0.002% (Oxervate, Dompé) had a positive effect on corneal nerve regeneration and sensation in patients with neurotrophic keratitis. The investigators reported their findings at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting in San Diego.

The authors carried out a retrospective study of patients seen at the New England Eye Center for neurotrophic keratitis from January 1, 2015, to March 31, 2022.All eligible patients completed a minimum of 4 weeks of treatment with cenegermin 0.002% and had in vivo confocal microscopy images from before and after treatment available.

For each evaluation, 3 representative in vivo confocal microscopy images were selected and graded in a masked fashion for total, main, and branch nerve density.

The group comprised of 25 patients with neurotrophic keratitis (mean age, 64.2; 28.0% male) and the control group that included 20 patients (mean age, 58.4; 40%male) were similar in age and sex.

The results showed that the median total, main, and branch nerve densities were lower in the neurotrophic keratitis group before treatment, respectively, 2,301.0, 1,653.5, and 547.9 µm/mm² compared with the respective controls values, 22,253.7, 10,130.95, and 12,080.9 (p<0.001 for all comparisons).

Following treatment with cenegermin, the densities increased to 5,306.7 for total (p=0.004), main 3,452.0 (p=0.005), and branch 1,987.9 (p=0.019) nerve densities. Corneal sensation also increased after treatment from 2.3 cm to 4.1 cm (p=0.001).

The authors concluded that the patients with neurotrophic keratitis who were treated for at least 4 weeks with cenegermin 0.002% had an overall increase in the total, main, and branch nerve densities. These results also demonstrated a significant increase in corneal sensation after cenegermin treatment.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Jessilin Quint, OD, MBA, FAAO, outlines her AOA's Optometry's Meeting 2025 presentation on nutrition and its impact on ocular health.
Carolyn Majcher, OD, FAAO, detailed a talk she gave alongside Mary Beth Yackey, OD, at Optometry's Meeting 2025.
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
Christi Closson, OD, FAAO, shares her excitement for the new Acuvue Oasys MAX 1-Day multifocal for astigmatism
Karen R. Hoffman, OD, shares how customizable scleral lenses can transform vision for patients with complex corneas, achieving 20/20 outcomes and enhanced comfort.
Janna Pham, OD, shares key takeaways from a corneal tomography session she presented alongside Travis Pfeifer, OD; and Matthew McGee, OD.
Jacob Lang, OD, FAAO, details early symptom relief demonstrated in as early as day 1 during AOA's Optometry's Meeting 2025.
When Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, began fitting scleral lenses 20 years ago, there was limited knowledge about conjunctival characteristics, scleral shape, and lens behavior.
Ioussifova details what sets Johnson & Johnson's new lens apart from the rest, which was launched at the American Optometric Association's Optometry's Meeting 2025.
Alongside Rachel Steele, OD, Rafieetary outlines what to look for in blurred disc margins and the importance of acting fast and sending patients to the ED when needed.
© 2025 MJH Life Sciences

All rights reserved.